These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 30027676)

  • 1. Robust Bayesian nonlinear mixed-effects modeling of time to positivity in tuberculosis trials.
    Burger DA; Schall R; Chen DG
    Pharm Stat; 2018 Sep; 17(5):615-628. PubMed ID: 30027676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robust fit of Bayesian mixed effects regression models with application to colony forming unit count in tuberculosis research.
    Burger DA; Schall R
    Stat Med; 2018 Feb; 37(4):544-556. PubMed ID: 29108125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Bayesian Nonlinear Mixed-Effects Regression Model for the Characterization of Early Bactericidal Activity of Tuberculosis Drugs.
    Burger DA; Schall R
    J Biopharm Stat; 2015; 25(6):1247-71. PubMed ID: 25322214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A generalized Bayesian nonlinear mixed-effects regression model for zero-inflated longitudinal count data in tuberculosis trials.
    Burger DA; Schall R; Jacobs R; Chen DG
    Pharm Stat; 2019 Jul; 18(4):420-432. PubMed ID: 30957394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of treatment response by colony forming units, time to culture positivity and the molecular bacterial load assay compared in a mouse tuberculosis model.
    de Knegt GJ; Dickinson L; Pertinez H; Evangelopoulos D; McHugh TD; Bakker-Woudenberg IAJM; Davies GR; de Steenwinkel JEM
    Tuberculosis (Edinb); 2017 Jul; 105():113-118. PubMed ID: 28610782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time to liquid culture positivity can substitute for colony counting on agar plates in early bactericidal activity studies of antituberculosis agents.
    Diacon AH; Maritz JS; Venter A; van Helden PD; Dawson R; Donald PR
    Clin Microbiol Infect; 2012 Jul; 18(7):711-7. PubMed ID: 21851489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detecting outliers when fitting data with nonlinear regression - a new method based on robust nonlinear regression and the false discovery rate.
    Motulsky HJ; Brown RE
    BMC Bioinformatics; 2006 Mar; 7():123. PubMed ID: 16526949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-treatment mycobacterial sputum load influences individual on-treatment measurements.
    Diacon AH; van der Merwe L; Demers AM; Von Groote-Bidlingmaier F; Venter A; Donald PR
    Tuberculosis (Edinb); 2014 Dec; 94(6):690-4. PubMed ID: 25444765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A robust method for the assessment of average bioequivalence in the presence of outliers and skewness.
    Burger DA; Schall R; van der Merwe S
    Pharm Res; 2021 Oct; 38(10):1697-1709. PubMed ID: 34676489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved power for TB Phase IIa trials using a model-based pharmacokinetic-pharmacodynamic approach compared with commonly used analysis methods.
    Svensson RJ; Gillespie SH; Simonsson USH
    J Antimicrob Chemother; 2017 Aug; 72(8):2311-2319. PubMed ID: 28520930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian analysis for nonlinear mixed-effects models under heavy-tailed distributions.
    De la Cruz R
    Pharm Stat; 2014; 13(1):81-93. PubMed ID: 24106083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skew-normal Bayesian nonlinear mixed-effects models with application to AIDS studies.
    Huang Y; Dagne G
    Stat Med; 2010 Oct; 29(23):2384-98. PubMed ID: 20603815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time to positivity in liquid culture predicts colony forming unit counts of Mycobacterium tuberculosis in sputum specimens.
    Diacon AH; van der Merwe L; Demers AM; von Groote-Bidlingmaier F; Venter A; Donald PR
    Tuberculosis (Edinb); 2014 Mar; 94(2):148-51. PubMed ID: 24456754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian analysis of nonlinear mixed-effects mixture models for longitudinal data with heterogeneity and skewness.
    Lu X; Huang Y
    Stat Med; 2014 Jul; 33(16):2830-49. PubMed ID: 24623529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bayesian quantile regression for nonlinear mixed-effects joint models for longitudinal data in the presence of mismeasured covariate errors.
    Huang Y; Chen J; Qiu H
    J Biopharm Stat; 2017; 27(5):741-755. PubMed ID: 27936356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early bactericidal activity of isoniazid in pulmonary tuberculosis. Optimization of methodology. The DATRI 008 Study Group.
    Hafner R; Cohn JA; Wright DJ; Dunlap NE; Egorin MJ; Enama ME; Muth K; Peloquin CA; Mor N; Heifets LB
    Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):918-23. PubMed ID: 9310014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Faropenem, Linezolid, and Moxifloxacin Regimen for Both Drug-Susceptible and Multidrug-Resistant Tuberculosis in Children: FLAME Path on the Milky Way.
    Deshpande D; Srivastava S; Nuermberger E; Pasipanodya JG; Swaminathan S; Gumbo T
    Clin Infect Dis; 2016 Nov; 63(suppl 3):S95-S101. PubMed ID: 27742640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standards for model-based early bactericidal activity analysis and sample size determination in tuberculosis drug development.
    Mockeliunas L; Faraj A; van Wijk RC; Upton CM; van den Hoogen G; Diacon AH; Simonsson USH
    Front Pharmacol; 2023; 14():1150243. PubMed ID: 37124198
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined quantitative tuberculosis biomarker model for time-to-positivity and colony forming unit to support tuberculosis drug development.
    Ayoun Alsoud R; Svensson RJ; Svensson EM; Gillespie SH; Boeree MJ; Diacon AH; Dawson R; Aarnoutse RE; Simonsson USH
    Front Pharmacol; 2023; 14():1067295. PubMed ID: 36998606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A robust bayesian random effects model for nonlinear calibration problems.
    Fong Y; Wakefield J; De Rosa S; Frahm N
    Biometrics; 2012 Dec; 68(4):1103-12. PubMed ID: 22551415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.